Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin barrier function proteins are a group of structural and regulatory proteins essential for maintaining the integrity, hydration, and protective functions of the skin’s outermost layer—the stratum corneum (SC). These proteins work in concert with lipids to form a physical, chemical, immunological, and microbiological barrier that prevents water loss (transepidermal water loss or TEWL) and protects against environmental insults such as pathogens, toxins, allergens, UV radiation, and mechanical injury. Key proteins include Filaggrin, Involucrin, Loricrin, Keratins 1 & 10, Desmoglein 1 & Desmocollin 1, and Corneodesmosin. Disruption or mutation in these key genes/proteins leads to compromised barrier function seen in conditions such as atopic dermatitis, ichthyosis vulgaris, SAM syndrome, or peeling skin disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin Barrier Function Proteins.